Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amnio Restore
- Development stage
- Unknown
- Lead developer
- BioLab Sciences
- Administration
- Injection
01
Overview
Amnio Restore is a human amniotic fluid-derived biologic allograft developed and manufactured by BioLab Sciences. It is obtained from the amniotic fluid of healthy donors during scheduled Cesarean sections. The product is processed into a sterile, injectable liquid that retains a concentrated profile of essential growth factors, cytokines, and proteins, including prostaglandin E2 (PGE2), WNT4, growth differentiation factor 11 (GDF-11), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), fibroblast growth factor (FGF), and transforming growth factor-beta (TGF-B). Amnio Restore is utilized in regenerative medicine to modulate inflammatory responses, promote cellular proliferation, and facilitate tissue repair and regeneration. It is primarily applied in clinical settings for wound care, orthopedics, and the treatment of soft tissue injuries.
- Brand names
- Amnio Restore
- Other names
- Amniotic liquid allograft
02
Targets
EGFR (Epidermal growth factor receptor)PDGFR (PDGFR family)VEGFR (VEGFR family)TGFBR (TGF-beta receptor)PTGER (Prostaglandin E2 receptor)FGFR (FGFR family)FZD (Frizzled receptor family)
Beyond the preview
Go deeper on Amnio Restore.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amnio Restore.